Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and

Edwin Wappl1, Alexandra Koschak, Michael Poteser

  • 1Institut für Biochemische Pharmakologie, Abteilung Pharmakologie und Toxikologie, Institut für Pharmazie, Universität Innsbruck, Peter-Mayrstrasse 1, A-6020 Innsbruck, Austria.

Insights

Investigating P/Q-type Ca(2+) channel mutations reveals functional consequences for ataxia. Some mutations cause channel dysfunction, supporting loss-of-function as a cause of episodic ataxia type 2 and progressive ataxia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Ataxia, including episodic ataxia type 2 (EA-2) and progressive ataxia (PA), is linked to mutations in the alpha1A (Ca(v)2.1alpha(1)) subunit of P/Q-type Ca(2+) channels.
  • Understanding the functional impact of these mutations is crucial for elucidating ataxia pathophysiology.

Purpose of the Study:

  • To investigate the functional consequences of specific P/Q-type Ca(2+) channel alpha1A subunit mutations (R1279Stop, AY1593/1594D associated with EA-2, and G293R associated with PA).
  • To determine if these mutations lead to a loss of channel function underlying ataxia.

Main Methods:

  • Human alpha1A cDNA with specific mutations were expressed in Xenopus oocytes and tsA-201 cells.
  • Electrophysiological analyses (current density, single channel conductance, current-voltage relationships, inactivation, recovery from inactivation) and biochemical analysis were performed.

Main Results:

  • The G293R mutation reduced current density without altering single channel conductance.
  • R1279Stop and AY1593/1594D mutations resulted in non-functional channels in tsA-201 cells, but AY1593/1594D showed partial function in oocytes.
  • G293R and AY1593/1594D shifted the current-voltage relationship, enhanced inactivation, and AY1593/1594D slowed recovery from inactivation. G293R altered fast channel gating.

Conclusions:

  • The findings support the hypothesis that a significant loss of P/Q-type Ca(2+) channel function contributes to the pathophysiology of EA-2 and PA.
  • Unlike some other EA-2 mutations, AY1593/1594D and G293R mutations result in at least partially functional channels.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...